相似文献
1
Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant.
Haematologica. 2019 Apr;104(4):e174-e177. doi: 10.3324/haematol.2018.196907. Epub 2018 Jul 5.
2
A case report of the second de novo acute myeloid leukemia (AML) following allogeneic stem cell transplantation in a patient with the first AML.
Korean J Intern Med. 2010 Mar;25(1):110-3. doi: 10.3904/kjim.2010.25.1.110. Epub 2010 Feb 26.
3
Acute myeloblastic leukemia in a patient with non-Hodgkin's lymphoma early after double peripheral blood stem-cell transplantation.
Transplantation. 2003 Jul 15;76(1):264-5. doi: 10.1097/01.TP.0000070488.12875.A0.
4
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
Blood. 2011 Jan 6;117(1):316-22. doi: 10.1182/blood-2010-07-294629. Epub 2010 Oct 6.
5
Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
Bone Marrow Transplant. 2002 Jun;29(12):999-1003. doi: 10.1038/sj.bmt.1703577.
6
Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?
Best Pract Res Clin Haematol. 2019 Mar;32(1):104-113. doi: 10.1016/j.beha.2019.02.011. Epub 2019 Feb 26.
7
Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab.
Leuk Lymphoma. 2013 Jan;54(1):174-6. doi: 10.3109/10428194.2012.691484. Epub 2012 May 21.
8
Azacitidine effectively reduces -mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation.
Leuk Lymphoma. 2018 Nov;59(11):2755-2756. doi: 10.1080/10428194.2018.1443335. Epub 2018 Apr 12.
9
ALK-negative anaplastic lymphoma after autologous stem cell transplant for relapsed diffuse large B-cell lymphoma.
Leuk Res. 2011 Jun;35(6):e59-60. doi: 10.1016/j.leukres.2010.11.018. Epub 2010 Dec 13.
10
Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia.
Am J Hematol. 2021 Jan;96(1):E15-E17. doi: 10.1002/ajh.26013. Epub 2020 Oct 30.
引用本文的文献
1
Benefits of serum protein electrophoresis as part of hematopoietic stem cell donor clearance.
EJHaem. 2024 Aug 29;5(5):1107-1109. doi: 10.1002/jha2.997. eCollection 2024 Oct.
2
Genetic evolution of follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype.
Haematologica. 2021 Oct 1;106(10):2673-2681. doi: 10.3324/haematol.2020.254854.
3
The safety of a therapeutic product composed of a combination of stem cell released molecules from adipose mesenchymal stem cells and fibroblasts.
Future Sci OA. 2020 May 29;6(7):FSO592. doi: 10.2144/fsoa-2020-0027.
4
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.
Haematologica. 2020 Jun;105(6):318-321. doi: 10.3324/haematol.2019.242206. Epub 2020 Apr 9.
5
The Safe and Efficacious Use of Secretome From Fibroblasts and Adipose-derived (but not Bone Marrow-derived) Mesenchymal Stem Cells for Skin Therapeutics.
J Clin Aesthet Dermatol. 2019 Aug;12(8):E57-E69. Epub 2019 Aug 1.
本文引用的文献
1
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.
Leukemia. 2016 Dec;30(12):2385-2395. doi: 10.1038/leu.2016.135. Epub 2016 May 20.
2
Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.
Blood. 2014 Oct 16;124(16):2544-53. doi: 10.1182/blood-2013-12-546309. Epub 2014 Aug 29.
3
Common progenitor cells in mature B-cell malignancies: implications for therapy.
Curr Opin Hematol. 2014 Jul;21(4):333-40. doi: 10.1097/MOH.0000000000000049.
4
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Nat Genet. 2014 Feb;46(2):176-181. doi: 10.1038/ng.2856. Epub 2013 Dec 22.
5
MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.
Nat Immunol. 2013 Oct;14(10):1084-92. doi: 10.1038/ni.2688. Epub 2013 Aug 25.
6
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
Blood. 2013 Mar 21;121(12):2253-63. doi: 10.1182/blood-2012-06-435842. Epub 2013 Jan 18.
7
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.
Cancer Discov. 2012 Jan;2(1):47-55. doi: 10.1158/2159-8290.CD-11-0208. Epub 2011 Dec 12.
8
Clonal evolution in cancer.
Nature. 2012 Jan 18;481(7381):306-13. doi: 10.1038/nature10762.
9
Pathogenesis of human B cell lymphomas.
Annu Rev Immunol. 2012;30:565-610. doi: 10.1146/annurev-immunol-020711-075027. Epub 2012 Jan 6.
10
Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor.
J Clin Oncol. 2010 Nov 1;28(31):e629-32. doi: 10.1200/JCO.2010.29.8992. Epub 2010 Aug 23.
Zotero 插件